Inadequate Empirical Antibiotic Therapy in Hospital Acquired Pneumonia

Area of Science:

• Infectious Diseases
• Microbiology
• Clinical Pharmacy

Background:

• Hospital-acquired pneumonia (HAP) management is challenged by inadequate empirical antibiotic therapy, a marker of poor antimicrobial stewardship.
• Understanding the microbiological landscape is crucial for optimizing HAP treatment protocols.

Purpose of the Study:

• To evaluate the efficacy of empirical antibiotic regimens for HAP using microbiological data.
• To identify patterns of antimicrobial resistance in HAP pathogens.

Main Methods:

• Prospective study of HAP cases from February to July 2014.
• Analysis of clinico-bacterial evidence, antibiotic use (pre- and post-culture), and antimicrobial resistance.
• Data analysis using Microsoft Office Excel 2007.

Main Results:

• Of 77 HAP cases, 65 were culture-positive; 48 were late-onset.
• Acinetobacter, Klebsiella, and Pseudomonas were common in late-onset HAP.
• Multidrug resistance was high, particularly in Acinetobacter, Klebsiella, and Pseudomonas isolates.
• Empirical therapies were inadequate in 70% of early-onset and 92% of late-onset HAP.
• Cephalosporin use was inadequate in early-onset HAP; polymyxins were avoided empirically.

Conclusions:

• Empirical antibiotic treatment for HAP is frequently inadequate, with higher failure rates in late-onset infections.
• Suboptimal empirical choices, such as cephalosporins in early-onset HAP and avoiding polymyxins in late-onset HAP, contribute to treatment failures.
• Practitioners must update their knowledge of local microbiological trends to guide empirical HAP therapy.